Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

AxCAmIL12p35

Recombinant adenovirus expressing mouse IL-12 p35 gene

Catalog number RDB01414
Resource name AxCAmIL12p35
Alternative name Adex1CAmIL12p35
Clone info. Recombinant adenovirus expressing mouse IL-12 p35 gene regulated by CAG promoter.
Vector backbone Adex1 (Adenovirus)
Size of vector backbone -
Growth remarks 5 percent FCS is fine.
Gene/insert name Mouse IL-12 p35 cDNA
Depositor|Developer Hamada, Hirofumi |
Other clones in our bank

External Database
Mouse IL-12 p35

          Reference sequence
            
           
          Remarks, protocol and/or map (gif) RDB01414.gif

          Distribution information

          Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
          Terms and conditions for distribution The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.(Cancer Gene Ther., 9, 44-52 (2002).) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
          Additional terms and conditions:
          Regarding resources containing CAG promoter: In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation for the CAG promoter (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991) and an acknowledgment to Dr. Jun-ich Miyazaki of the Osaka University are requested.
          Ordering Please visit Information of Request for Distribution.[link] 
          Order form 
          [Credit Card Payment]  [Bank Transfer Payment]
          Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]
          提供案内 (日本国内) [open/close]

          提供条件 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Cancer Gene Ther., 9, 44-52 (2002).)。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。
          付加的提供条件:
          CAGプロモータを含むリソースについて: 利用者は、研究成果の公表にあたってCAGプロモータの文献 (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991)を引用し、大阪大学 宮崎純一博士への謝辞の表明を必要とする。
          提供依頼 手続きの詳細は、「提供申込みについて[link]」をご覧ください。
          提供依頼書 [Word]
          提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]
          遺伝子組換え生物の受入れ確認書 [Word]
          備考 【追加提供依頼書】受入れ確認書(書式J)
          組換え体提供にかかる書式が必要です。

          Catalog # Resource name Availability Shipping form Fee (non-profit org.)
          RDB01414 AxCAmIL12p35 Under QC test. Please contact us. Virus, lysate of infected cell culture

          check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.

          How to cite this biological resource

          Materials & Methods section:

          The AxCAmIL12p35 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01414).

          Reference section:

          Further references such as user reports and related articles (go to bottom)


          References and tips

          Featured content


          QC test results


          References

          Original, user report and related articles

          user_report Ojima T., The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Int. J. Oncol., 28, 947-953 (2006). PMID 16525645.
          user_report Furumoto K., Interleukin-12-gene transduction makes DCs from tumor-bearing mice an effective inducer of tumor-specific immunity in a peritoneal dissemination model. Immunol. Lett., 83, 13-20 (2002). PMID 12057850.
          user_report Furumoto K., Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses. Int. J. Cancer., 87, 665-672 (2000). PMID 10925360.

          2023.05.02

          GNP_filter3_RDBDEP_html_230501.pl